Street Expectation From PetMed Express, Inc. ($PETS) 2Q21 Earnings?

PetMed Express, Inc. (NASDAQ:PETS) pet pharmacy operator, is reporting second quarter earnings results on Monday 26th October 2020, before market open.

The consensus estimates from Thomson Reuters are income of $ 0.40 per share from $ 77.05 million in revenue.

For the full year, analysts predict revenues of $ 313.31 million, while looking forward to income of $ 1.52 per share.

Previous Quarter Performance

PetMed Express, Inc. unfold income for the first quarter of $ 0.39 per share, from the revenue of $ 96.20 million. The quarterly earnings expanded 50.00 percent while revenues gained 20.27 percent compared with the same quarter last year. The top line results outshined analysts by $ 8.27 million or 9.41 percent.

Stock Performance

On Friday, shares of PetMed Express, Inc. has traded high as $ 30.85 and has cracked $ 29.72 on the downward trend, reaching $ 30.66 with volume of 574.40 thousand shares.

According to the previous trading day, closing price of $ 30.66, representing a 41.46 % increase from the 52 week low of $ 21.20 and a 30.08 % decrease over the 52 week high of $ 42.89.

The company has a market capital of $ 621.54 million and is part of the Consumer Defensive sector and Pharmaceutical Retailers industry.

Recent Stock Dividend Announcement

On July 20, 2020, the board of directors authorized quarterly dividend of $ 0.28 per share to holders of record as of the close of business on July 31, 2020, with payment date of August 7, 2020 and ex-dividend date on July 30, 2020.

Conference Call

PetMed Express, Inc. will be hosting a conference call at 8:00 AM eastern time on 26th October 2020, to discuss its 2Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.1800petmeds.com

PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers.

error: Content is protected !!
Exit mobile version